Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $5.22 Billion
- Q4 2024
A detailed history of Eventide Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,606,938 shares of MIRM stock, worth $137 Million. This represents 2.07% of its overall portfolio holdings.
Number of Shares
2,606,938
Previous 3,445,363
24.33%
Holding current value
$137 Million
Previous $134 Million
19.78%
% of portfolio
2.07%
Previous 2.37%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$345 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$240 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$170 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million4.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$127 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.93B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...